Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FluBlok, a recombinant hemagglutinin influenza vaccine

1 Nov 2008

Abstract excerpt

FluBlok, a recombinant trivalent hemagglutinin (HA) vaccine produced in insect cell culture using the baculovirus expression system, provides an attractive alternative to the current egg-based trivalent inactivated influenza vaccine (TIV) manufacturing process. FluBlok contains three times more HA than TIV and does not contain egg-protein or preservatives. This review discusses the four main clinical studies that...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Influenza Virus Research Studies
Share to Transgenic Plants and Applications
Share to Viral Infectious Diseases and Gene Expression in Insects

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19453397
DOI: 10.1111/j.1750-2659.2008.00053.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FluBlok, a recombinant hemagglutinin influenza vaccinePMID 19453397Read ↗

Production of a novel influenza vaccine using insect cells: protection against drifted strainsSemantic proximity Read ↗

Insect Cell-Based Quadrivalent Seasonal Influenza Virus-like Particles Vaccine Elicits Potent Immune Responses in MiceSemantic proximity Read ↗

Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performanceSemantic proximity Read ↗

Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved EffectivenessSemantic proximity Read ↗

Quadrivalent Ann Arbor strain live-attenuated influenza vaccineSemantic proximity Read ↗

Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine productionSemantic proximity Read ↗

Protection of commercial turkeys following inactivated or recombinant H5 vaccine application against the 2015 U.S. H5N2 clade 2.3.4.4 highly pathogenic avian influenza virusSemantic proximity Read ↗

Generation of A Triple Insert Live Avian Herpesvirus Vectored Vaccine Using CRISPR/Cas9-Based Gene EditingSemantic proximity Read ↗

The Quest for a Universal Flu Vaccine: Headless HA 2.0Semantic proximity Read ↗

Safety and Immunogenicity of an Inactivated Quadrivalent Influenza Vaccine in Children 6 Months through 8 Years of AgeSemantic proximity Read ↗

The End of B/Yamagata Influenza Transmission — Transitioning from Quadrivalent VaccinesSemantic proximity Read ↗

Critical assessment of influenza VLP production in Sf9 and HEK293 expression systemsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.